GnoMine, the DNA identity ecosystem built on blockchain technology, enables individuals to securely store, manage, share and monetize their own genomic data while incentivizing participation through rewards.


Information silos restrain medical research.  GnoMine incentivizes open participation in biomedical research.



Privacy of DNA is a growing concern for individuals.  GnoMine enables secure storage, exploration and sharing of DNA data.


Today, DNA is bought and sold without owner compensation. GnoMine enables individuals to transact directly with ecosystem players.

See some more about our solution


Ecosystem players providing genomic services

We anticipate many ecosystem players will develop genomics related products and services and make these available within the ecosystem.

Decentralized, secure storage of DNA data

A human genome may require up to ~200 Gb of storage space, this is why GnoMine utilizes decentralized, secure storage of DNA data.

Encrypted client storage of personal health information

The surest path to protection of personal health information (e.g. health histories) is local, encrypted storage on the participant’s own device.

Smart contracts to facilitate data transactions

Smart contracts are executable code stored to the blockchain which control the transfer of GnoMine tokens and DNA data between ecosystem players.

A native token for transaction settlements

GnoMine will introduce a token to be used for settling payments, this token will provide a basis for incentivizing participation of individuals and service providers within the ecosystem.

Why GnoMine?

Until now, the best approach for genomics companies has been to provide consumers with valuable and actionable use cases (ancestry, lifestyle reports) in return for sample and data submission. Despite a curiosity for learning about their DNA, many consumers have failed to see a clear value proposition for why they should do it now. The marketplace we create will increase the ways consumers can obtain and interact with their data.

“Blockchain solves the problem of manipulation. When I speak about it in the West, people say they trust Google, Facebook, or their banks. But the rest of the world doesn’t trust organizations and corporations that much — I mean Africa, India, the Eastern Europe, or Russia. It’s not about the places where people are really rich. Blockchain’s opportunities are the highest in the countries that haven’t reached that level yet.”

Vitalik Buterin, inventor of Ethereum

“With the world’s population projected to top 8 billion by 2025, it is possible that as many as 25% of the population in developed nations and half of that in less-developed nations will have their genomes sequenced (comparable to the current worldwide distribution of Internet users.”

Big Data: Astronomical or Genomical? Stephens et al. PLOS Biology

“Blockchain, also known as distributed ledger technologies, show significant promise in addressing the trust and transparency required for a digital world. Opportunities exist to rethink cooperation and control governance, financial control, flow of wealth, the trust gap, and transforming transparency of organizations. Consequently, society faces a unique opportunity with blockchain to transform how we engage with each other.”

Ray Wang

When consumers participate in genetic testing, they typically grant these companies “a perpetual, royalty-free, worldwide, transferable license to use their DNA and to sublicense and distribute the resulting analysis” even after they stop using the website or service.

“Every company is at risk of being disrupted by a trusted version of itself.”


Our team


Rapidly decreasing DNA sequencing costs and increasing demand by biotechnology and pharmaceutical companies are creating a multi-billion dollar market for big DNA data. While individual consumers have much to gain from personal DNA sequencing, most do not participate due to gaps in access and trust.

Direct-to-consumer genomics companies 23andMe and have accumulated DNA data from millions of participants. These companies act as intermediaries between individuals and industry to broker genomic data, however, as consumers become more educated, this arrangement is creating a widening trust gap vulnerable to disruption by disintermediation.

Blockchain technology is "an open, distributed ledger that can record transactions between two parties efficiently and in a verifiable and permanent way."1 Blockchain enables trusted transactions between parties without intermediaries and is ideally suited to address issues of trust, including data ownership and privacy.

GnoMine, the DNA identity ecosystem built on blockchain technology, enables individuals to securely store, manage, share and monetize their own genomic data while incentivizing participation through rewards. Data ownership, privacy and security are built-in features of the blockchain enabling GnoMine to close the trust gap. The economics of GnoMine are based on the exchange of tokens between participants in the ecosystem. Token economics creates a virtuous cycle driving adoption of DNA sequencing through industry subsidies and incentivizing participation through token payments ultimately driving network growth and value creation. Network growth creates value for individuals and industry by encouraging additional subsidies, directly connecting individuals and industry, and disintermediating direct-to-consumer genomics companies.